A New Blood Biomarker of Endoscopic Disease Activity: A Step Forward in the Treat-To-Target Paradigm for Crohn’s Disease?

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2019.12.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Objective Evaluation for Treat to Target in Crohn’s Disease

Journal of Gastroenterology
Gastroenterology
2020English

A Step Forward in Disease Modelling for Mitochondrial Diseases

Stem Cell Investigation
2017English

From Blood Development to Disease: A Paradigm for Clinical Translation

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2019English

Update of Endoscopic Management of Crohn’s Disease Strictures

Intestinal Research
Gastroenterology
2020English

Seeking a New Paradigm for Alzheimer’s Disease: Considering the Roles of Inflammation, Blood-Brain Barrier Dysfunction, and Prion Disease

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2017English

In Development—A New Paradigm for Understanding Vascular Disease

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2017English

Mycobacterial Infection Influences Bone Biomarker Levels in Crohn’s Disease

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2018English

Blood Biomarker for Parkinson Disease: Peptoids

npj Parkinson's Disease
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy